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Abstract: Merkel cell tumors, a type of cutaneous round-cell tumors, are rarely observed in dogs and cats. This tumor type originates from
cutaneous neuroendocrine cells. In the present study, the morphology of canine and feline Merkel cell tumors and their immunoexpression
of neuron-specific enolase, cytokeratin, chromogranin A, Ki67, and metallothionein were evaluated using histopathological and
immunohistochemical methods. The canine Merkel cell tumor displayed a diffuse morphological pattern, whereas the feline tumor
displayed a solid morphological pattern. Both tumors were positive for neuron-specific enolase and cytokeratin, but negative for
chromogranin A. The Ki67 indexes in the canine and feline tumors were 7% and 25%, respectively. The expression of metallothionein
was minimal in both tumors. In conclusion, this paper describes the detailed histopathological and immunohistochemical features of
uncommon canine and feline Merkel cell tumors, including metallothionein expression, which has never been studied in such tumors
previously.
Key words: Merkel cell tumor, dog, cat, immunohistochemistry

1. Introduction
Merkel cell tumors (MCTs) are a rare neuroendocrine
neoplasm. This tumor type arises from Merkel cells of the
skin, the origin of which is not fully understood. There are
hypotheses that suggest a crest or epidermal origin (1–3).
It is hypothesized that these cells have somatosensory,
chemosensory, secretory, trophic, or inductive functions
in the development of peripheral nerves and epidermal
structures (2). Tumors arising from Merkel cells can be
benign or malignant. In humans, MCTs are a form of
the highly aggressive Merkel cell carcinoma (MCC) and
are classified into 3 subtypes: trabecular (classic pattern),
intermediate (solid pattern), and small cell (diffuse
pattern) (1). MCTs are rarely diagnosed in dogs and cats;
therefore, little is known about MCT pathogenesis, breed
predilections, and etiology in these species. Canine MCTs
are considered to be a benign neoplasm (3,4), whereas
feline MCTs are considered to be malignant, similar to their
human equivalent (4). The tumor is usually in the form of
an intradermal, unencapsulated mass extending into the
subcutis. The neoplastic cells are round, resembling other
cutaneous round-cell tumors such as plasmacytoma, mastcell tumors, histiocytoma, transmissible venereal tumors,
balloon-cell melanoma, and nonepitheliotropic lymphoma.
* Correspondence: mateusz.mikiewicz@uwm.edu.pl
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Epidermal and adnexal invasions are not observed (3).
Due to the nonspecific morphology and rarity of MCTs
in dogs and cats, these tumors are often misdiagnosed by
routine hematoxylin and eosin (H&E) staining. Therefore,
additional immunohistochemical experiments should be
conducted to properly diagnose MCTs (3). The neoplastic
cells of MCTs in animals and MCC in humans typically
express neuroendocrine markers, such as neuron-specific
enolase (NSE), chromogranin A (CGA), synaptophysin
(SYP), protein gene product 9.5 (PGP 9.5), substance P
(SP), vasoactive intestinal polypeptide (VIP), insulin,
gastrin, and epithelial marker cytokeratin (AE1/AE3)
(3–6). However, CGA expression is occasionally absent in
MCC (4).
The metallothioneins (MTs) are a family of cysteinerich proteins located in the cytoplasm and nucleus
during the S phase of the cell cycle (7). The key functions
of these proteins are neutralization of free radicals,
immunomodulation, and apoptosis inhibition. There are
2 forms of MTs, varying by metal occupancy: metal-free
(apo-MT) and metal-bound (holo-MT) (8). Holo-MT has
anticarcinogenic activity because it protects DNA from
damaging agents, whereas apo-MT is correlated with
tumor growth and progression. The interaction of apo-
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MT sulfhydryl groups with p53 leads to p53 inactivation
and initiation of neoplastic cell proliferation (9,10).
Overexpression of MT in human tumors, and particularly
in breast, ovarian, uterine, and prostate carcinomas, is
related to high proliferative activity of neoplastic cells
and to therapeutic resistance. However, downregulation
of MT expression in hepatocellular carcinomas is
associated with poor prognosis (11). In certain tumors,
i.e. primary pulmonary carcinoma, MT expression is
positively correlated with the expression of the cellular
proliferation marker Ki67 (12,13). In dogs, the expression
of MT has been studied in apocrine gland tumors,
mammary gland tumors, melanotic tumors, and primary
pulmonary carcinomas. In cats, studies have been limited
to melanotic tumors and primary pulmonary carcinomas.
The expression of MT in both MCTs and human MCC has
not been previously evaluated.
The aim of the present study was to examine the
immunoexpression of NSE, CGA, AE1/AE3, MT, and
Ki67 in 2 cases of MCTs (canine and feline).

feline tissue sections were processed together with the
evaluated slides (NSE–brain cortex; CGA–gastric mucosa;
AE1/AE3–skin; MT–mammary gland; Ki67–tonsil). As
negative controls, the primary antibody was either replaced
with mouse IgG2a (DAKO, Glostrup, Denmark) at the
appropriate dilution (for NSE, Ki67, MT, and AE1/AE3) or
omitted (for CGA). Brown precipitate was regarded as an
indicator of a positive reaction. The slides were evaluated
by light microscopy (BX52, Olympus, Tokyo, Japan) using
Cell^B (Olympus) software. The immunoreactivities
of NSE, CGA, AE1/AE3, and MT were evaluated using
digital microphotography and were described as absent
(–), minimal (10%–30%), moderate (30%–70%), or high
(70%–100%) in a high-power field (HPF) (400×). The
mitotic figures were counted in 10 randomly chosen areas
of each slide (HPF 400×). Ki67 immunoexpression was
evaluated quantitatively in 10 randomly chosen areas of
each slide (HPF 400×). The Ki67 index was expressed as a
percentage of positively stained cells.

2. Case history
The tumors in both species presented as an intradermal
mass located in the buccal area. The canine tumor was
obtained from a 5-year-old intact mongrel bitch, and the
feline tumor was obtained from a 13-year-old neutered
European shorthair male. Both tumors were surgically
excised, sampled, immediately fixed in 10% buffered
formalin, and routinely processed. Histological diagnosis
was based on H&E and Mallory trichrome staining
(staining kits from Bio-Optica, Milan, Italy). Sections
destined for immunohistochemistry underwent antigen
retrieval before staining. The immunohistochemical
examination was performed using primary antibodies,
visualization systems, and a chromogen, as summarized
in the Table. The slides were counterstained with Mayer’s
hematoxylin. As positive controls, both canine and

3. Results and discussion
In the dog, the tumor was unencapsulated, located in a
deep area of the skin, and did not exhibit invasion into the
skin or the adnexal structures. The cells were small (Figure
1) and surrounded by thick fibrovascular stroma, as
confirmed by Mallory trichrome staining (inset of Figure
1). The nuclei were hyperchromatic, with an average of
7 per 10 HPFs of mitotic figures (400×). The cytoplasm
was eosinophilic and sparse. The neoplastic cells had
positive, high (approximately 80% of the neoplastic cells)
intracytoplasmic granular or diffuse expression of NSE
(Figure 2) and high (90% of the neoplastic cells) perinuclear
expression of AE1/AE3 (Figure 3). CGA expression was
absent (Figure 4). Cytoplasmic and membranous MT
expression was minimal (approximately 15% of the cells)
(Figure 5). The Ki67 index was 7% (Figure 6).

Table. Primary antibodies used for the particular methods of antigen retrieval and visualization.
Primary antibody

Clone

Dilution

Source

Antigen retrieval

Visualization system

Neuron-specific
enolase (NSE)

Monoclonal mouse
antihuman BBS/NC/VI-H14

1:100

DAKO,
Denmark

2 × 5 min* TrisEDTA
buffer pH 9

EnVision + System-HRP,
Mouse (DAB)‡

Cytokeratin
(AE1/AE3)

Monoclonal mouse
antihuman AE1/AE3

1:50

DAKO,
Denmark

2 × 5 min* TrisEDTA
buffer pH 9

EnVision + System-HRP,
Mouse (DAB)‡

Metallothionein
(MT)

Monoclonal mouse
antimetallothionein clone E9

1:50

DAKO,
Denmark

2 × 5 min* TrisEDTA
buffer pH 9

EnVision + System-HRP,
Mouse (DAB)‡

Chromogranin A
(CGA)

Polyclonal rabbit antihuman

Ready-to-use

DAKO,
Denmark

2 × 5 min* TrisEDTA
buffer pH 9

Impress Universal Reagent
Anti-Mouse/Rabbit Ig Peroxidase§

Ki67

Monoclonal mouse
antihuman MIB-1

1:75

DAKO,
Denmark

2 × 5 min* TrisEDTA
buffer pH 9

EnVision + System-HRP,
Mouse (DAB)‡

*Antigen retrieval was conducted in a microwave oven at 650 W; ‡DAKO, Glostrup, Denmark; §Vector Laboratories Inc., Burlingame, CA, USA.
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Figure 1. Merkel cell tumor in dog skin. Clusters of small neoplastic cells surrounded by abundant fibrovascular stroma – small cell
subtype (H&E). Inset: Collagen fibers surrounding clusters of neoplastic cells (Mallory trichrome).
Figure 2. Merkel cell tumor in dog skin. Positive immunolabeling of neoplastic cells to NSE, DAB.
Figure 3. Merkel cell tumor in dog skin. Positive immunolabeling of neoplastic cells to AE1/AE3, DAB.
Figure 4. Merkel cell tumor in dog skin. No CGA expression in neoplastic cells, DAB.
Figure 5. Merkel cell tumor in dog skin. Cytoplasmic and membranous expression of MT in neoplastic cells, DAB.
Figure 6. Merkel cell tumor in dog skin. Expression of Ki67 in neoplastic cells, DAB.

In the cat, the tumor was unencapsulated, located in a
deep area of the skin, and did not show epidermal or follicular
invasion. The tumor was composed of monomorphic round
cells that were arranged in sheets (Figure 7) and separated
by delicate fibrovascular stroma (confirmed by Mallory
trichrome staining, inset of Figure 7). The centrally located
nuclei were round to oval in shape, with evenly dispersed
chromatin and a sharply defined nuclear membrane. The
number of mitotic figures was 56 per 10 HPFs (400×).
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The cytoplasm was pale, eosinophilic, and moderate. The
neoplastic cells showed high (approximately 90% of the
neoplastic cells) cytoplasmic granular or diffuse expression
of NSE (Figure 8), high (approximately 90% of the neoplastic
cells) cytoplasmic perinuclear expression of AE1/AE3
(Figure 9), and no CGA expression (Figure 10). Cytoplasmic
and nuclear expression of MT (Figure 11) was minimal and
was observed in approximately 30% of the neoplastic cells.
The Ki67 index was 25% (Figure 12).
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Figure 7. Merkel cell tumor in cat skin. Round neoplastic cells divided by thin fibrovascular stroma – intermediate subtype (HE). Inset:
Delicate collagen fibers surrounding packets of neoplastic cells (Mallory trichrome).
Figure 8. Merkel cell tumor in cat skin. Positive immunolabeling of neoplastic cells to NSE, DAB.
Figure 9. Merkel cell tumor in cat skin. Positive immunolabeling of neoplastic cells to AE1/AE3, DAB.
Figure 10. Merkel cell tumor in cat skin. No CGA expression in neoplastic cells, DAB.
Figure 11. Merkel cell tumor in cat skin. Cytoplasmic and nuclear expression of MT in neoplastic cells, DAB.
Figure 12. Merkel cell tumor in cat skin. Expression of Ki67 in neoplastic cells, DAB.

The results of the present study suggest that canine
MCTs correspond to the diffuse pattern (smallcell subtype) of human MCC, whereas feline MCTs
correspond to the solid pattern (intermediate subtype).
In both cases, the immunoreactivities of the neoplastic
cells indicated positivity for NSE and AE1/AE3, which
suggests a neuroectodermal origin of the cells. Similar
immunolabeling was also observed by other authors (4–

6,14,15). In the present study, the neoplastic cells were
CGA negative in both the canine and the feline MCTs,
which corresponds to CGA-negative cases of human MCC
(15).
Both the canine and the feline MCTs had minimal
MT expression. In human large-cell neuroendocrine
carcinoma of the lung, the expression of MT is also
minimal or even absent (16). A complete lack of MT
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expression is associated with amplified spontaneous and
mutagenic DNA damage (10). High MT expression in
canine apocrine gland tumors as well as in canine and
feline melanomas is positively associated with tumor
grade. Similar associations have been observed in many
human tumors, e.g., cutaneous melanoma, adenoid cystic
carcinoma of the salivary gland, and breast carcinoma (i.e.
invasive carcinoma of no special type, invasive lobular
carcinoma, tubular carcinoma, cribriform carcinoma,
mucinous carcinoma, carcinoma with medullary features,
and invasive papillary carcinoma) (9). However, only 25%
of canine cutaneous melanomas and only 6% of feline
cutaneous melanomas show expression of MT (10). Given
that holo-MT protects DNA from damage and that apoMT is related to tumor growth and progression, future
research on the role of both MT forms in the pathogenesis
of canine and feline MCTs will be necessary (9,10).
Mitotic activity and the Ki67 index were low in the
canine MCT, whereas in the feline MCT mitotic activity
was high and the Ki67 index was moderate. High mitotic
activity and a high Ki67 index are indicative of malignancy

in many cutaneous neoplasms (17,18). In neuroendocrine
tumors, the Ki67 and mitotic indexes have been considered
to be malignancy indicators, although Ki67 is a more
precise malignancy marker (19). These results suggest that
the growth and progression of the evaluated feline MCT
were probably more dynamic than those of the evaluated
canine MCT. However, mitotic activity or the Ki67 index
alone is not sufficient to determine the malignancy of a
tumor. The major malignancy criterion is the metastatic
potential of the neoplastic cells (20). Unfortunately, followup information was not available in the present study.
In this report, the histopathological and
immunohistochemical findings of unusual MCTs were
described in a dog and a cat. In the presented cases, the
canine and feline MCTs showed high NSE and AE1/AE3
expression, indicating neuroectodermal origin. The lack
of CGA expression in both evaluated tumors suggests
that this marker cannot be used as a diagnostic marker in
canine and feline MCTs. To the best of our knowledge, this
is the first immunohistochemical study to evaluate MT
expression in canine and feline MCTs.
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